Cerebral cortical dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:268950
Who is this for?
Show terms as
21Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cerebral cortical dysplasia (also referred to as focal cortical dysplasia or cortical malformation) is a rare congenital brain malformation characterized by abnormal development of the cerebral cortex, the outer layer of the brain responsible for higher cognitive functions, motor control, and sensory processing. The condition arises from disrupted neuronal migration and organization during fetal brain development, leading to areas of abnormally structured cortical tissue. These malformations primarily affect the central nervous system and can vary widely in extent and location within the brain. The hallmark clinical feature of cerebral cortical dysplasia is epilepsy, which is often drug-resistant and may present in infancy or childhood. Seizures can be focal or generalized depending on the location and extent of the cortical abnormality. Additional symptoms may include intellectual disability, developmental delay, motor impairment, and speech or language difficulties. The severity of symptoms is highly variable and correlates with the size, location, and type of cortical malformation present. Diagnosis is typically established through brain magnetic resonance imaging (MRI), which can reveal characteristic abnormalities such as cortical thickening, blurring of the gray-white matter junction, and abnormal gyral patterns. Electroencephalography (EEG) is used to characterize seizure activity. Treatment primarily focuses on seizure management with antiepileptic medications. In cases of medically refractory epilepsy, surgical resection of the dysplastic cortical area may be considered and can be curative in selected patients. Supportive therapies including physical therapy, occupational therapy, and speech therapy are important components of comprehensive management. Genetic counseling may be offered, as some forms of cortical dysplasia have been associated with mutations in genes involved in the mTOR signaling pathway.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Jun 2022Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong

Chinese University of Hong Kong

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Cerebral cortical dysplasia.

View clinical trials →

No actively recruiting trials found for Cerebral cortical dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Cerebral cortical dysplasia community →

Specialists

21 foundView all specialists →
AS
Antonio Carlos Dos Santos
Specialist
1 Cerebral cortical dysplasia publication
CG
Camila Araujo Bernardino Garcia
Specialist
1 Cerebral cortical dysplasia publication
AH
Ana Paula Andrade Hamad
Specialist
1 Cerebral cortical dysplasia publication
UC
Ursula Thome Costa
Specialist
1 Cerebral cortical dysplasia publication
AS
Americo Ceiki Sakamoto
Specialist
1 Cerebral cortical dysplasia publication
GR
Guglielmo Riccio
Specialist
1 Cerebral cortical dysplasia publication
SA
Salvatore Aversa
Specialist
1 Cerebral cortical dysplasia publication
HM
Helio Rubens Machado
Specialist
1 Cerebral cortical dysplasia publication
BG
Brunetta Guaragni
Specialist
1 Cerebral cortical dysplasia publication
FR
Francesco Maria Risso
Specialist
1 Cerebral cortical dysplasia publication
MS
Marcelo Volpon Santos
Specialist
1 Cerebral cortical dysplasia publication
OM
Orrin Devinsky, MD
NEW YORK, NY
Specialist
PI on 4 active trials
GP
Gaetan POULEN, MD, PhD
Specialist
PI on 1 active trial
JP
Jérôme HONNORAT, Pr
Bron
Specialist

Rare Disease Specialist

PI on 2 active trials
LP
Lorenzo Pinelli
Specialist
1 Cerebral cortical dysplasia publication
AP
Aurélie Kas, Pr
Specialist
PI on 1 active trial
CM
Charles Raybaud, M.D.
Specialist
PI on 1 active trial
JP
Jeannette T Bensen, Ph.D
Specialist
PI on 1 active trial
JP
Jonathan S Berg, MD, PhD
Specialist
PI on 1 active trial
JC
J Helen Cross, MB ChB
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cerebral cortical dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cerebral cortical dysplasiaForum →

No community posts yet. Be the first to share your experience with Cerebral cortical dysplasia.

Start the conversation →

Latest news about Cerebral cortical dysplasia

Disease timeline:

New recruiting trial: Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong

A new clinical trial is recruiting patients for Cerebral cortical dysplasia

New recruiting trial: Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue)

A new clinical trial is recruiting patients for Cerebral cortical dysplasia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cerebral cortical dysplasia

What is Cerebral cortical dysplasia?

Cerebral cortical dysplasia (also referred to as focal cortical dysplasia or cortical malformation) is a rare congenital brain malformation characterized by abnormal development of the cerebral cortex, the outer layer of the brain responsible for higher cognitive functions, motor control, and sensory processing. The condition arises from disrupted neuronal migration and organization during fetal brain development, leading to areas of abnormally structured cortical tissue. These malformations primarily affect the central nervous system and can vary widely in extent and location within the brain

Which specialists treat Cerebral cortical dysplasia?

21 specialists and care centers treating Cerebral cortical dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.